At Brill, we believe that science and research are the foundation of progress and
the driving force behind a healthier society.
At Brill, we believe that science and research are the foundation of progress and the driving force behind a healthier society.
The Brill Group’s R&D division, known as Brill Engines, was established in 2019 as a result of our long-standing commitment to innovation. Since then, we have focused on developing advanced technologies and solutions in the fields of ophthalmology, pulmonology, dermatology and diagnostics.
Starting with ophthalmology, our activities have expanded into new areas with the same purpose: to improve quality of life through scientific innovation.
Our main objective is the research and development of innovative pharmaceutical products and medical devices, with a particular focus on eye health.
We work to solve complex challenges through science, driving advances that transform healthcare.
PIPELINE
The first portable, non-invasive device to assist in the assessment of the condition of the eye’s surface. This is our first completed project and is currently in clinical use.
Formulation and optimisation of various ophthalmic solutions, focusing on stability, biocompatibility and therapeutic efficacy for a range of eye conditions.
A unique, versatile and reliable in vitro system for the accurate detection of various functionalised biomolecules.